Cidara therapeutics, inc. (CDTX)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14
ASSETS
Current assets:
Cash and cash equivalents

64,314

50,268

73,800

44,573

57,407

74,562

83,780

88,954

52,218

60,813

54,276

78,012

82,198

85,367

24,622

29,271

51,704

62,562

64,471

122,301

58,124

22,796

Restricted cash

10,000

10,000

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, prepaid expenses and other current assets

6,307

5,546

-

-

-

2,567

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt Securities, Available-for-sale

-

-

-

-

-

-

-

-

-

14,501

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

792

-

-

-

-

-

-

-

-

-

-

-

-

-

Short-term investments

-

-

-

-

-

-

4,494

14,246

13,973

-

9,876

0

7,888

19,252

54,687

57,818

44,954

44,952

49,947

-

-

0

Accounts receivable

-

-

-

-

-

-

0

41

288

321

321

215

-

0

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

-

-

3,664

3,173

2,869

-

3,687

2,753

1,719

2,035

1,730

1,576

1,195

779

1,270

1,142

859

704

947

749

278

217

Total current assets

80,621

65,814

77,488

47,746

60,276

77,129

91,961

105,994

68,990

77,670

66,203

79,803

91,281

105,398

80,579

88,231

97,517

108,218

115,365

123,050

58,402

23,013

Property and equipment, net

394

429

496

577

635

712

786

824

936

1,044

1,043

1,165

1,292

1,374

1,463

1,603

1,634

1,684

1,550

831

814

863

Operating lease right-of-use asset

1,447

1,632

1,810

1,983

2,131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

1,635

1,101

1,902

1,446

1,271

1,271

62

190

321

321

190

190

190

190

190

190

72

72

73

72

1,567

474

Total assets

84,097

68,976

81,696

51,752

64,313

79,112

92,809

107,008

70,247

79,035

67,436

81,158

92,763

106,962

82,232

90,024

99,223

109,974

116,988

123,953

60,783

24,350

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable

2,560

1,887

2,679

1,787

1,713

2,846

2,439

2,611

2,999

2,590

1,777

4,817

1,912

2,909

2,957

1,517

1,266

3,095

1,338

854

1,696

1,177

Accrued liabilities

3,741

4,068

4,320

3,585

3,786

3,883

3,385

4,790

4,516

4,257

3,186

3,461

3,440

3,338

3,033

2,003

1,545

1,415

1,825

1,459

1,740

1,622

Accrued compensation and benefits

2,235

3,658

2,932

2,526

2,049

2,824

2,585

2,143

1,921

2,571

1,987

1,713

1,534

2,662

2,242

1,605

1,245

1,464

1,112

755

373

414

Deferred revenue

10,279

9,803

10,900

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of lease liability

848

818

790

762

730

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of term loan

9,966

9,965

9,958

9,948

9,938

9,928

667

0

2,083

2,667

1,667

667

-

0

-

-

-

-

-

-

-

-

Contingent forward purchase obligation

-

-

0

0

681

411

4,486

5,374

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

29,629

30,199

31,579

18,608

18,897

19,892

13,562

14,918

11,519

12,085

8,617

10,658

6,886

8,909

8,232

5,125

4,056

5,974

4,275

3,068

3,809

3,213

Lease liability

716

942

1,155

1,362

1,554

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Term loan, less debt issuance costs

-

-

-

-

-

-

9,253

9,910

7,809

-

8,185

9,165

9,813

-

-

-

-

-

-

-

-

-

Term loan, less debt issuance costs

-

-

-

-

-

-

-

-

-

7,206

-

-

-

9,794

-

-

-

0

-

-

-

-

Other long-term liabilities

-

-

0

0

0

81

62

42

-

0

61

71

75

80

85

90

89

88

88

28

31

34

Total liabilities

30,345

31,141

32,734

19,970

20,451

19,973

22,877

24,870

19,328

19,291

16,863

19,894

16,774

18,783

8,317

5,215

4,145

6,062

4,363

3,096

3,840

3,247

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

Stockholders' equity:
Preferred stock

0

0

-

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

Common stock, $0.0001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 40,559,511 shares issued and outstanding at March 31, 2020 and 33,838,466 shares issued and outstanding at December 31, 2019

4

3

3

3

3

3

3

3

2

2

2

2

2

2

1

1

1

1

4

4

3

-

Additional paid-in capital

-

-

-

-

-

-

276,323

274,912

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

330,876

297,659

294,763

280,622

279,155

277,871

-

-

217,073

209,140

186,534

184,967

183,051

181,840

153,199

151,853

150,365

149,416

148,255

147,308

2,512

1,859

Accumulated other comprehensive loss

-

-

-

-

-

-

-1

-3

-18

-8

-1

0

-4

-1

-17

-4

-2

-8

-5

-

-

-

Accumulated deficit

-277,128

-259,827

-245,800

-248,800

-235,296

-218,735

-206,393

-192,774

-166,138

-149,390

-135,962

-123,705

-107,060

-93,662

-79,268

-67,041

-55,286

-45,497

-35,629

-26,455

-20,041

-13,304

Total stockholders' equity

53,752

37,835

48,962

31,782

43,862

59,139

69,932

82,138

50,919

59,744

50,573

61,264

75,989

88,179

73,915

84,809

95,078

103,912

112,625

120,857

-17,526

-11,445

Total liabilities and stockholders' equity

84,097

68,976

81,696

51,752

64,313

79,112

92,809

107,008

70,247

79,035

67,436

81,158

92,763

106,962

82,232

90,024

99,223

109,974

116,988

123,953

60,783

24,350

Series X Convertible Preferred Stock
Preferred stock

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders' equity

0

0

0

0

0

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-